Bharat Biotech’s intranasal COVID-19 vaccine to cost ₹800 for private markets

Bharat Biotech’s intranasal COVID-19 vaccine to cost ₹800 for private markets

Image for representational purposes only. | Photo Credit: The Hindu Hyderabad-based Bharath Biotech said Tuesday that its nasally administered vaccine, iNCOVACC, would be available for public use from the fourth week of January and cost ₹800 for private markets and ₹325 for governments.  iNCOVACC will be rolled out as a booster dose for those above […]

Continue Reading
COVID-19 | India records 2,424 new infections, 3 deaths

COVID-19 | India records 2,424 new infections, 3 deaths

According to the Health Ministry, 218.99 crore doses of COVID-19 vaccine have been administered in the country so far. According to the Health Ministry, 218.99 crore doses of COVID-19 vaccine have been administered in the country so far. India saw a single day rise of 2,424 new coronavirus infections taking the total tally of COVID-19 […]

Continue Reading